Recruiting OBSERVATIONAL NCT06597240

Home Monitoring During Chemoradiation (AMCOR)

At-home Monitoring of Patients During Chemoradiation for Oesophageal CanceR: the AMCOR Trial

Sponsor: Nova Biomedical

Conditions Locally Advanced Oesophageal Cancer

Interventions AMCOR

Updated 4 times since 2024 Last updated: Aug 8, 2025 Started: May 15, 2025 Primary completion: Oct 31, 2026 Completion: Oct 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Locally Advanced Oesophageal Cancer and is currently actively recruiting participants. Nova Biomedical leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Jul 2025 — Sep 2025 [monthly]

Recruiting
May 2025 — Jul 2025 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Oct 2024 — May 2025 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nova Biomedical
Siemens Corporation, Corporate Technology
University Medical Center Groningen

Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Groningen, Netherlands